Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Aridis Pharmaceuticals stock | $5.78

Learn how to easily invest in Aridis Pharmaceuticals stock.

Aridis Pharmaceuticals, Inc
NASDAQ: ARDS - USD
BIOTECHNOLOGY
$4.95
-$0.04 (-0.80%)

Aridis Pharmaceuticals, Inc is a biotechnology business based in the US. Aridis Pharmaceuticals shares (ARDS) are listed on the NASDAQ and all prices are listed in US Dollars. Aridis Pharmaceuticals employs 33 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Aridis Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ARDS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Aridis Pharmaceuticals stock price (NASDAQ: ARDS)

Use our graph to track the performance of ARDS stocks over time.

Aridis Pharmaceuticals shares at a glance

Information last updated 2021-07-31.
Latest market close$5.78
52-week range$4.55 - $8.50
50-day moving average $6.44
200-day moving average $6.44
Wall St. target price$17.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.19

Buy Aridis Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aridis Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aridis Pharmaceuticals price performance over time

Historical closes compared with the close of $5.78 from 2021-05-28

1 week (2021-07-23) N/A
1 month (2021-07-02) -22.83%
3 months (2021-05-03) -8.69%
6 months (2021-01-30) N/A
1 year (2020-07-30) N/A
2 years (2019-07-30) N/A
3 years (2018-07-30) N/A
5 years (2016-07-30) N/A

Aridis Pharmaceuticals financials

Revenue TTM $1 million
Gross profit TTM $-15,956,000
Return on assets TTM -71.84%
Return on equity TTM 0%
Profit margin 0%
Book value $0.99
Market capitalisation $56.1 million

TTM: trailing 12 months

Shorting Aridis Pharmaceuticals shares

There are currently 25,701 Aridis Pharmaceuticals shares held short by investors – that's known as Aridis Pharmaceuticals's "short interest". This figure is 11% up from 23,162 last month.

There are a few different ways that this level of interest in shorting Aridis Pharmaceuticals shares can be evaluated.

Aridis Pharmaceuticals's "short interest ratio" (SIR)

Aridis Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Aridis Pharmaceuticals shares currently shorted divided by the average quantity of Aridis Pharmaceuticals shares traded daily (recently around 45089.473684211). Aridis Pharmaceuticals's SIR currently stands at 0.57. In other words for every 100,000 Aridis Pharmaceuticals shares traded daily on the market, roughly 570 shares are currently held short.

However Aridis Pharmaceuticals's short interest can also be evaluated against the total number of Aridis Pharmaceuticals shares, or, against the total number of tradable Aridis Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aridis Pharmaceuticals's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Aridis Pharmaceuticals shares in existence, roughly 0 shares are currently held short) or 0.0043% of the tradable shares (for every 100,000 tradable Aridis Pharmaceuticals shares, roughly 4 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aridis Pharmaceuticals.

Find out more about how you can short Aridis Pharmaceuticals stock.

Aridis Pharmaceuticals share dividends

We're not expecting Aridis Pharmaceuticals to pay a dividend over the next 12 months.

Aridis Pharmaceuticals share price volatility

Over the last 12 months, Aridis Pharmaceuticals's shares have ranged in value from as little as $4.55 up to $8.5. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aridis Pharmaceuticals's is 0.1617. This would suggest that Aridis Pharmaceuticals's shares are less volatile than average (for this exchange).

Aridis Pharmaceuticals overview

Aridis Pharmaceuticals, Inc. , a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-105, a fully human IgG1 mAb, which is in Phase II trials to target gram-negative bacteria P. aeruginosa; AR-101, a human IgM mAb, which is in Phase IIa clinical trials for the treatment of hospital-acquired pneumonia (HAP)and ventilator-associated pneumonia (VAP) caused by P. aeruginosa serotype O11; AR-401 that is in preclinical stage to treat infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-501, an anti-infective therapy, which is in Phase I/IIa clinical trial to manage chronic lung infections in cystic fibrosis patients and acute pneumonia in HAP and VAP patients.

Stocks similar to Aridis Pharmaceuticals

Frequently asked questions

What percentage of Aridis Pharmaceuticals is owned by insiders or institutions?
Currently 40.861% of Aridis Pharmaceuticals shares are held by insiders and 13.104% by institutions.
How many people work for Aridis Pharmaceuticals?
Latest data suggests 33 work at Aridis Pharmaceuticals.
When does the fiscal year end for Aridis Pharmaceuticals?
Aridis Pharmaceuticals's fiscal year ends in December.
Where is Aridis Pharmaceuticals based?
Aridis Pharmaceuticals's address is: 983 University Avenue, Los Gatos, CA, United States, 95032
What is Aridis Pharmaceuticals's ISIN number?
Aridis Pharmaceuticals's international securities identification number is: US0403341045
What is Aridis Pharmaceuticals's CUSIP number?
Aridis Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 040334104

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site